Clinical trial
Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve…
NCT00491244 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00491244 |
|---|---|
| Title | Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C |
| Official title | Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin Versus Pegylated Interferon Alfa-2a Alone for Treatment-naïve Hemodialysis Patients With Chronic Hepatitis C |
| Lead sponsor | National Taiwan University Hospital, Other |
| Collaborators | National Science and Technology Council, Taiwan Department of Health, Executive Yuan, R.O.C. (Taiwan) |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Drug |
| Interventions | Peginterferon alfa-2a and ribavirin, Peginterferon alfa-2a |
| Enrollment | 377 |
| Start date | Jun 1, 2007 |
| Primary completion | Sep 1, 2013 |
| Completion | Sep 1, 2013 |
| First posted | Jun 26, 2007 |
| Last update posted | Feb 10, 2014 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: